Gender-based differences in treatment and outcome among HIV patients in South India

Journal of Women's Health

Volumn 17, Issue 9, 2008, Pages 1471-1475

  Kumarasamy, N ^a,d   Venkatesh, K K ^b   Cecelia, A J ^a   Devaleenol, B ^a   Saghayam, S ^a   Yepthomi, T ^a   Balakrishnan, P ^a   Flanigan, T ^b,c   Solomon, S ^a   Mayer, K H ^b,c  

^a VHS Medical Centre India   (India)

^b BROWN UNIVERSITY   (United States)

^c MIRIAM HOSPITAL   (United States)

^d YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; HEMOGLOBIN; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD LEVEL; BODY MASS; CD4 LYMPHOCYTE COUNT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DATA BASE; DIARRHEA; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INDIA; LACTIC ACIDOSIS; LIPOATROPHY; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PANCREATITIS; PERIPHERAL NEUROPATHY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RASH; SEX DIFFERENCE; STEVENS JOHNSON SYNDROME; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; DATABASES, FACTUAL; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SEX FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

EID: 56249124259     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2007.0670     Document Type: Article

References (23)

1. UNAIDS. UNAIDS/WHO AIDS epidemic update. Available at www.unaids.org/epidemic-update/ Accessed August 9, 2007.
2. Gandhi M, Aweeka F, Greenblatt RM, Blasche TF. Sex differences in pharmacokinetics and pharmacodynamics. Ann Rev Pharmacol Toxicol. 2004;44:499-523.
3. Gandhi M, Bacchetti P, Miotti P, Quinn TC, Veronese F, Greenblatt RM. Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis 2002;35:313-322.
4. Mocroft A, Gill MJ, Davidson W, Phillips AN. Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? J Acquir Immune Defic Synd 2000;24:475-482.
5. Sterling T, Vlahov D, Astemborski J, Hoover DR, Margolick J, Quinn TC. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 2001;344:720-725.
6. Moore A, Kirk O, Johnson AM, et al. Virologic, immunologic, and clinical response to highly active antiretroviral therapy: The ender issues revisited. J Acquir Immune Defic Synd 2003;32:452-461.
7. Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis 2003;36:79-85.
8. Kumarasamy N, Solomon S, Chaguturu, SK et al. The changing natural history of HIV disease: Before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis 2005;41:1525-1528.
9. Newmann S, Sarin P, Kumarasamy N, et al. Marriage, monogamy and HIV: A profile of HIV-infected women in south India. Int J STD AIDS 2000;11:250-253.
10. Rogers M, Gopalakrishnan G, Kumarasamy N, et al. HIV in couples in South India: Implications for prevention. Int J STD AIDS 2005;16:442-445.
11. WHO. Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach - 2003 revision. Available at www.who.int/hiv/pub/prev_care/en/arvrevision 2003en.pdf Accessed August 2, 2007.
12. Benson C, Kaplan JE, Masur H, Pau A, Holmes KK. Treating opportunistic infections among HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America: University of Colorado Health Sciences Center, Centers for Disease Control, National Institutes of Health, University of Washington; 2005. MMWR Recommendations and Reports. 2004;53(RR-15):1-112.
13. Kumarasamy N, Chagututu S, Mayer KH, et al. Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J Acquir Immune Defic Syndr 2004;37:1574-1576.
14. Gangakhedkar R, Bentley ME, Divekar AD, et al. Spread of HIV infection in married monogamous women in India. JAMA 1997;278:2090-2092.
15. Bharucha K, Sastry J, Shrotri A, et al. Feasibility of voluntary counselling and testing services for HIV among pregnant women presenting in labour in Pune, India. Int J STD AIDS 2005;16:553-555.
16. Solomon S, Kouyoumdjian FG, Cecelia AJ, James R, James L, Kumarasamy N. Why are people getting tested? Self-reported reasons for seeking voluntary counseling and testing at a clinic in Chennai, India. AIDS Behav 2006;10:415-420.
17. WHO. Summary country profile for HIV/AIDS treatment scale-up: India, July 24, 2007. Available at www.who.int/hiv/HIVCP_IND.pdf
18. Rogers A, Meundi A, Amma A, et al. HIV-related knowledge, attitudes, perceived benefits, and risks of HIV testing among pregnant women in rural southern India. AIDS Patient Care STDs 2006;20:803-811.
19. Lawn S, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: Long-term incidence and risk factors in a South African cohort. AIDS 2005;19:2109-2116.
20. + responses to nucleoside analogue therapy for HIV infection. J Acquir Immune Defic Syndr 2000;24:316-324.
21. Farzadegan H, Hoover DR, Astemborski J, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998;352:1510-1514.
22. Eisenman D, Bogart LM, Bird CE, et al. Differential diffusion of HIV technologies by gender: The case of highly active antiretroviral therapy. AIDS Patient Care STDs 2007;21:390-399.
23. Gardner L, Holmberg SD, Moore J, et al., for the HIV Epidemiology Research Study Group. Use of highly active antiretroviral therapy in HIV-infected women: Impact of HIV specialist care. J Acquir Immune Defic Synd 2002;29:69-75.